Catabasis

-$0.03 (-1.81%) Today
-$0.03 (-1.84%) As of 10:28 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Catabasis and other ETFs, options, and stocks.

About CATB

Catabasis Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of novel therapeutics. Its lead product candidate is edasalonexent, which is intended for the treatment of Duchenne muscular dystrophy.

CEO
Jill C. Milne
Employees
20
Headquarters
Boston, Massachusetts
Founded
2008

CATB Key Statistics

Market Cap
125.43M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
987.01K
High Today
$1.65
Low Today
$1.62
Open Price
$1.65
Volume
399.16K
52 Week High
$8.59
52 Week Low
$1.25

CATB Earnings

-$0.61
-$0.41
-$0.20
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 9, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure